 Connection
Nanette Santoro to Estrogen Replacement Therapy
This is a "connection" page, showing publications Nanette Santoro has written about Estrogen Replacement Therapy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
7.726 |
|
|
|
-
Hofmann G, Santoro N. Navigating the Debate on Menopausal Hormonal Therapy and Practical Prescribing. Obstet Gynecol Clin North Am. 2026 Sep; 53(3):411-422.
Score: 0.887
-
Santoro N, Liss J. Compounded Bioidentical Hormones: Myths and Realities. Clin Obstet Gynecol. 2021 12 01; 64(4):793-802.
Score: 0.652
-
Santoro N, Roeca C, Peters BA, Neal-Perry G. The Menopause Transition: Signs, Symptoms, and Management Options. J Clin Endocrinol Metab. 2021 01 01; 106(1):1-15.
Score: 0.612
-
Crandall CJ, Diamant A, Santoro N. Safety of vaginal estrogens: a systematic review. Menopause. 2020 03; 27(3):339-360.
Score: 0.577
-
Santoro N, Worsley R, Miller KK, Parish SJ, Davis SR. Role of Estrogens and Estrogen-Like Compounds in Female Sexual Function and Dysfunction. J Sex Med. 2016 Mar; 13(3):305-16.
Score: 0.437
-
Pinkerton JV, Santoro N. Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women. Menopause. 2015 Sep; 22(9):926-36.
Score: 0.423
-
Al-Safi ZA, Santoro N. Menopausal hormone therapy and menopausal symptoms. Fertil Steril. 2014 Apr; 101(4):905-15.
Score: 0.381
-
Santoro N. Symptoms of menopause: hot flushes. Clin Obstet Gynecol. 2008 Sep; 51(3):539-48.
Score: 0.260
-
James TT, Dowling NM, Ferrer Simó C, Salazar H, Van Hulle CA, Ennis G, Johnson AL, Wyman MF, McLester-Davis LWY, Gooding DC, Fischer B, Bouges S, Umucu E, Kara F, Kling JM, Manson JE, Brinton EA, Cedars MI, Lobo RA, Neal-Perry G, Santoro NF, Naftolin F, Harman SM, Pal L, Miller VM, Kantarci K, Gleason CE. Association between central adiposity and cognitive domain function in recently postmenopausal women: an analysis from the KEEPS-Cog substudy of the Kronos Early Estrogen Preventive Study. Menopause. 2026 Feb 01; 33(2):151-160.
Score: 0.218
-
Kantarci K, Kara F, Tosakulwong N, Fought AJ, Schwarz CG, Senjem ML, Kendall-Thomas J, Min P, Lowe VJ, Jack CR, Kapoor E, Fields JA, Bailey KR, James TT, Faubion L, Lobo RA, Manson JE, Pal L, Hammers DB, Brinton EA, Malek-Ahmadi M, Cedars MI, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE. Long-term amyloid PET and MRI outcomes in a menopausal hormone therapy trial. Alzheimers Dement. 2026 02; 22(2):e71067.
Score: 0.218
-
Manson JE, Bassuk SS, Harman SM, Brinton EA, Cedars MI, Lobo R, Merriam GR, Miller VM, Naftolin F, Santoro N. Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause. 2006 Jan-Feb; 13(1):139-47.
Score: 0.216
-
Santoro NF, Lawley SD, Sammel MD, Johnson J. Prolonging youth or prolonging perimenopause? Beware the Monkey's Paw. Menopause. 2025 Oct 01; 32(10):978-982.
Score: 0.213
-
Faubion LL, Mak E, Kara F, Tosakulwong N, Lesnick TG, Fought AJ, Reid RI, Schwarz CG, Kendall-Thomas J, Kapoor E, Fields JA, Bailey KR, James TT, Lobo RA, Manson JE, Pal L, Hammers DB, Brinton EA, Malek-Ahmadi M, Cedars M, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE, Kantarci K. Long-term effects of 4 years of menopausal hormone therapy on white matter integrity. Menopause. 2025 Sep 01; 32(9):818-828.
Score: 0.211
-
Kara F, Tosakulwong N, Lesnick TG, Fought AJ, Kendell-Thomas J, Kapoor E, Faubion LL, Schwarz CG, Senjem ML, Fields JA, Min PH, Lowe VJ, Jack CR, Bailey KR, James TT, Lobo RA, Manson JE, Pal L, Hammers DB, Malek-Ahmadi M, Cedars MI, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE, Kantarci K. Associations of blood pressure with white matter hyperintensities later in life; influence of short-term menopausal hormone therapy. Menopause. 2025 Jan 01; 32(1):12-22.
Score: 0.202
-
Santoro N. Basics of the menopause transition. Menopause. 2024 Oct 01; 31(10):921-922.
Score: 0.198
-
Kantarci K, Tosakulwong N, Lesnick TG, Kara F, Kendall-Thomas J, Kapoor E, Fields JA, James TT, Lobo RA, Manson JE, Pal L, Hammers DB, Malek-Ahmadi M, Cedars MI, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE. Cardiometabolic outcomes in Kronos Early Estrogen Prevention Study continuation: 14-year follow-up of a hormone therapy trial. Menopause. 2024 Jan 01; 31(1):10-17.
Score: 0.187
-
Lieman HJ, Adel TE, Forst C, von Hagen S, Santoro N. Effects of aging and estradiol supplementation on GH axis dynamics in women. J Clin Endocrinol Metab. 2001 Aug; 86(8):3918-23.
Score: 0.159
-
Pinkerton JV, Faubion SS, Kaunitz AM, Liu JH, Manson JE, Santoro NF, Shifren JL, Stuenkel CA. The National Academies of Science, Engineering, and Medicine (NASEM) Report on Compounded Bioidentical Hormone Therapy. Menopause. 2020 11; 27(11):1199-1201.
Score: 0.151
-
El Khoudary SR, Venugopal V, Manson JE, Brooks MM, Santoro N, Black DM, Harman M, Naftolin F, Hodis HN, Brinton EA, Miller VM, Taylor HS, Budoff MJ. Heart fat and carotid artery atherosclerosis progression in recently menopausal women: impact of menopausal hormone therapy: The KEEPS trial. Menopause. 2020 03; 27(3):255-262.
Score: 0.144
-
Miller VM, Naftolin F, Asthana S, Black DM, Brinton EA, Budoff MJ, Cedars MI, Dowling NM, Gleason CE, Hodis HN, Jayachandran M, Kantarci K, Lobo RA, Manson JE, Pal L, Santoro NF, Taylor HS, Harman SM. The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned? Menopause. 2019 09; 26(9):1071-1084.
Score: 0.139
-
El Khoudary SR, Zhao Q, Venugopal V, Manson JE, Brooks MM, Santoro N, Black DM, Harman SM, Cedars MI, Hopkins PN, Kearns AE, Miller VM, Taylor HS, Budoff MJ. Effects of Hormone Therapy on Heart Fat and Coronary Artery Calcification Progression: Secondary Analysis From the KEEPS Trial. J Am Heart Assoc. 2019 08 06; 8(15):e012763.
Score: 0.139
-
Taylor HS, Tal A, Pal L, Li F, Black DM, Brinton EA, Budoff MJ, Cedars MI, Du W, Hodis HN, Lobo RA, Manson JE, Merriam GR, Miller VM, Naftolin F, Neal-Perry G, Santoro NF, Harman SM. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS). JAMA Intern Med. 2017 10 01; 177(10):1471-1479.
Score: 0.122
-
Santoro N, Allshouse A, Neal-Perry G, Pal L, Lobo RA, Naftolin F, Black DM, Brinton EA, Budoff MJ, Cedars MI, Dowling NM, Dunn M, Gleason CE, Hodis HN, Isaac B, Magnani M, Manson JE, Miller VM, Taylor HS, Wharton W, Wolff E, Zepeda V, Harman SM. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study. Menopause. 2017 03; 24(3):238-246.
Score: 0.117
-
Owen CM, Pal L, Mumford SL, Freeman R, Isaac B, McDonald L, Santoro N, Taylor HS, Wolff EF. Effects of hormones on skin wrinkles and rigidity vary by race/ethnicity: four-year follow-up from the ancillary skin study of the Kronos Early Estrogen Prevention Study. Fertil Steril. 2016 Oct; 106(5):1170-1175.e3.
Score: 0.112
-
Santoro N, Epperson CN, Mathews SB. Menopausal Symptoms and Their Management. Endocrinol Metab Clin North Am. 2015 Sep; 44(3):497-515.
Score: 0.106
-
Gleason CE, Dowling NM, Wharton W, Manson JE, Miller VM, Atwood CS, Brinton EA, Cedars MI, Lobo RA, Merriam GR, Neal-Perry G, Santoro NF, Taylor HS, Black DM, Budoff MJ, Hodis HN, Naftolin F, Harman SM, Asthana S. Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study. PLoS Med. 2015 Jun; 12(6):e1001833; discussion e1001833.
Score: 0.104
-
Harman SM, Black DM, Naftolin F, Brinton EA, Budoff MJ, Cedars MI, Hopkins PN, Lobo RA, Manson JE, Merriam GR, Miller VM, Neal-Perry G, Santoro N, Taylor HS, Vittinghoff E, Yan M, Hodis HN. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med. 2014 Aug 19; 161(4):249-60.
Score: 0.098
-
Huang G, Wang D, Zeb I, Budoff MJ, Harman SM, Miller V, Brinton EA, El Khoudary SR, Manson JE, Sowers MR, Hodis HN, Merriam GR, Cedars MI, Taylor HS, Naftolin F, Lobo RA, Santoro N, Wildman RP. Intra-thoracic fat, cardiometabolic risk factors, and subclinical cardiovascular disease in healthy, recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS). Atherosclerosis. 2012 Mar; 221(1):198-205.
Score: 0.082
-
Santoro N, Komi J. Prevalence and impact of vaginal symptoms among postmenopausal women. J Sex Med. 2009 Aug; 6(8):2133-42.
Score: 0.069
-
Miller VM, Black DM, Brinton EA, Budoff MJ, Cedars MI, Hodis HN, Lobo RA, Manson JE, Merriam GR, Naftolin F, Santoro N, Taylor HS, Harman SM. Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res. 2009 Sep; 2(3):228-39.
Score: 0.068
-
Aubuchon M, Santoro N. Lessons learned from the WHI: HRT requires a cautious and individualized approach. Geriatrics. 2004 Nov; 59(11):22-6.
Score: 0.050
-
Santoro N. The menopause transition: an update. Hum Reprod Update. 2002 Mar-Apr; 8(2):155-60.
Score: 0.041
-
Pinkerton JV, Liu JH, Santoro NF, Thurston RC, Joffe H, Faubion SS, Manson JE. Workshop on normal reference ranges for estradiol in postmenopausal women: commentary from The North American Menopause Society on low-dose vaginal estrogen therapy labeling. Menopause. 2020 06; 27(6):611-613.
Score: 0.037
-
Santoro N, Banwell T, Tortoriello D, Lieman H, Adel T, Skurnick J. Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women. Am J Obstet Gynecol. 1998 Apr; 178(4):732-41.
Score: 0.032
-
Davis SR, Lambrinoudaki I, Lumsden M, Mishra GD, Pal L, Rees M, Santoro N, Simoncini T. Menopause. Nat Rev Dis Primers. 2015 04 23; 1:15004.
Score: 0.026
-
Santoro N, Schneyer AL, Ibrahim J, Schmidt CL. Gonadotropin and inhibin concentrations in early pregnancy in women with and without corpora lutea. Obstet Gynecol. 1992 Apr; 79(4):579-85.
Score: 0.021
-
Wolff E, Pal L, Altun T, Madankumar R, Freeman R, Amin H, Harman M, Santoro N, Taylor HS. Skin wrinkles and rigidity in early postmenopausal women vary by race/ethnicity: baseline characteristics of the skin ancillary study of the KEEPS trial. Fertil Steril. 2011 Feb; 95(2):658-62.e1-3.
Score: 0.019
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|